Robert Andrew Douglas - Sep 15, 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Stock symbol
RMD
Transactions as of
Sep 15, 2022
Transactions value $
-$2,945,622
Form type
4
Date filed
9/16/2022, 07:18 PM
Previous filing
Aug 22, 2022
Next filing
Oct 17, 2022
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -1.15K -2.12% $0.00 53K Sep 15, 2022 ResMed Common Stock 1.15K $58.24 Direct F4
transaction RMD ResMed Common Stock Options Options Exercise $0 -16.9K -31.89% $0.00 36.1K Sep 15, 2022 ResMed Common Stock 16.9K $58.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 This transaction was executed in multiple trades at prices ranging from $232.45 to $232.91. The price reported above reflects the weighted average sale price.
F3 Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares.
F4 Represents date options first became exercisable. Options vest 1/3 per year.